Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €470.00 EUR
Change Today 0.00 / 0.00%
Volume 0.0
RHPP On Other Exchanges
Symbol
Exchange
EN Paris
EN Paris
New York
OTC US
BrsaItaliana
Mexico
EN Paris
Frankfurt
Frankfurt
NASDAQ GM
As of 11:50 AM 06/16/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for sanofi-titr part10%87 (RHPP)

Although debt as a percent of total capital increased at Sanofi over the last fiscal year to 20.84%, it is still in-line with the Pharmaceuticals industry's norm. Additionally, there are enough liquid assets to satisfy current obligations. Accounts Receivable are typical for the industry, with 75.55 days worth of sales outstanding. Last, Sanofi is among the most efficient in its industry at managing inventories, with only 213.69 days of its Cost of Goods Sold tied up in inventory.
View Balance Sheet In U.S. Dollar
Currency in
Millions of Euros
As of:Dec 31
2011
Restated
EUR
Dec 31
2012
Restated
EUR
Dec 31
2013
Restated
EUR
Dec 31
2014
EUR
4 Year
Trend
Assets    
Cash and Equivalents4,124.06,381.08,257.07,341.0
Short-Term Investments35.056.059.09.0
Trading Asset Securities90.040.024.098.0
TOTAL CASH AND SHORT TERM INVESTMENTS4,249.06,477.08,340.07,448.0
Accounts Receivable8,042.07,507.06,831.07,149.0
Other Receivables2,145.02,097.02,023.01,861.0
TOTAL RECEIVABLES10,187.09,604.08,854.09,010.0
Inventory6,051.06,379.06,352.06,562.0
Prepaid Expenses256.0258.0264.0296.0
Other Current Assets115.0183.0116.0121.0
TOTAL CURRENT ASSETS20,858.022,901.023,926.023,437.0
Gross Property Plant and Equipment18,210.019,124.019,561.020,880.0
Accumulated Depreciation-7,460.0-8,546.0-9,379.0-10,484.0
NET PROPERTY PLANT AND EQUIPMENT10,750.010,578.010,182.010,396.0
Goodwill38,582.038,073.037,134.039,197.0
Long-Term Investments2,109.03,056.04,147.03,745.0
Loans Receivable, Long Term573.0695.0676.0711.0
Deferred Tax Assets, Long Term3,637.04,369.04,144.04,860.0
Deferred Charges, Long Term4,600.04,083.01,993.01,441.0
Other Intangibles19,039.016,109.013,402.013,102.0
Other Long-Term Assets524.0535.0451.0503.0
TOTAL ASSETS100,672.0100,399.096,055.097,392.0
    
LIABILITIES & EQUITY    
Accounts Payable3,183.03,190.03,003.03,651.0
Accrued Expenses1,957.01,882.01,813.01,912.0
Short-Term Borrowings980.0254.0470.0321.0
Current Portion of Long-Term Debt/Capital Lease1,987.03,560.03,706.01,219.0
Current Portion of Capital Lease Obligations12.013.013.015.0
Current Income Taxes Payable1,060.0932.0978.0948.0
Other Current Liabilities, Total4,417.04,051.03,959.04,981.0
TOTAL CURRENT LIABILITIES13,584.013,869.013,929.013,032.0
Long-Term Debt12,419.010,654.010,364.013,229.0
Capital Leases80.065.050.047.0
Minority Interest170.0134.0129.0148.0
Pension & Other Post-Retirement Benefits3,836.05,242.04,025.04,873.0
Deferred Tax Liability Non-Current6,530.05,932.05,060.04,105.0
Other Non-Current Liabilities7,860.07,151.05,594.05,838.0
TOTAL LIABILITIES44,309.042,913.039,022.041,124.0
Common Stock2,682.02,653.02,649.02,639.0
Additional Paid in Capital53,439.052,916.053,072.052,553.0
Treasury Stock-933.0-207.0-244.0-694.0
Comprehensive Income and Other1,005.01,990.01,427.01,622.0
TOTAL COMMON EQUITY56,193.057,352.056,904.056,120.0
TOTAL EQUITY56,363.057,486.057,033.056,268.0
TOTAL LIABILITIES AND EQUITY100,672.0100,399.096,055.097,392.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RHPP:FP €470.00 EUR 0.00

RHPP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actavis plc $304.76 USD +1.20
Amgen Inc $164.31 USD +1.72
Bayer AG €142.21 EUR +2.60
Gilead Sciences Inc $100.69 USD -0.31
Novo Nordisk A/S kr376.80 DKK +7.10
View Industry Companies
 

Industry Analysis

RHPP

Industry Average

Valuation RHPP Industry Range
Price/Earnings 25.0x
Price/Sales 3.2x
Price/Book 1.9x
Price/Cash Flow 15.8x
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI-TITR PART10%87, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.